Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MIAMI, June 22, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) today announced that the Kidney Disease Improving Global Outcomes (KDIGO) organization has updated its Clinical Practice...
-
MIAMI, June 15, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announces an update to the topline data analysis of the Phase 3, double-blind, placebo-controlled study of its investigational...
-
MIAMI, June 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq:OPK) announced today that GeneDx, a business unit of OPKO’s BioReference Laboratories division, extended its relationship with the...
-
Approximately 68% of all insured lives now have access to RAYALDEEOn track to reach 75% of insured lives by year endIncrease to 70 field based nephrology sales representatives underway MIAMI, June ...
-
MIAMI, May 18, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability...
-
Highlights 4Kscore’s ability to predict aggressive prostate cancer Showcasing 4Kscore and Claros 1 Point-of-Care System at Exhibit Booth #904 MIAMI, May 15, 2017 (GLOBE NEWSWIRE) -- OPKO Health,...
-
MIAMI, May 09, 2017 (GLOBE NEWSWIRE) -- In a release issued earlier today by OPKO Health, Inc. (NASDAQ:OPK), please note that the headline should read "OPKO Health Reports 2017 Financial and...
-
U.S. commercial launch of RAYALDEE underway4Kscore test utilization continues to grow; Level 1 CPT code and CMS pricing in placePediatric global phase 3 initiated and Japanese registration trial for...
-
MIAMI, May 08, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), a multinational biopharmaceutical and diagnostics company, will announce operating and financial results for the three...
-
MIAMI, March 22, 2017 (GLOBE NEWSWIRE) -- OPKO Pharmaceuticals LLC, a subsidiary of OPKO Health, Inc. (NASDAQ:OPK) announces that the Company has received orphan drug designation from the U.S. Food...